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Abstract 
Background: Young people living with long term conditions are vulnerable to health service disengagement. This endangers 
their long term health. Studies report requests for digital forms of communication - email, text, social media - with their 
health care team. Digital clinical communication is troublesome for the UK NHS. 
Aim: To present the research protocol for evaluating the impacts and outcomes of digital clinical communications for young 
people living with long term conditions and provide critical analysis of their use, monitoring and evaluation by NHS 
providers. 
Methods: The research involves: 1) Patient and Public Involvement activities with 16-24 year olds with and without long 
term health conditions; 2) six literature reviews; 3) case studies – the main empirical part of the study – and 4) synthesis and 
a consensus meeting. Case studies use a mixed methods design. Interviews and non-participant observation of practitioners 
and patients communicating in up to 20 specialist clinical settings will be combined with data, aggregated at the case level 
(non-identifiable patient data), on a range of clinical outcomes meaningful within the case and across cases. We will describe 
the use of digital clinical communication from the perspective of patients, clinical staff, support staff and managers, 
interviewing up to 15 young people and 15 staff per case study. Outcome data includes emergency admissions, A&E 
attendance and DNA rates. Case studies will be analysed to understand impacts of digital clinical communication on patient 
health outcomes, health care costs and consumption, ethics and patient safety. 
 
Keywords 
Young adults, transition care, long term conditions, digital clinical communication, email, VoIP, mobile health, mixed 
methods, information governance, digital technology 
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Background  
Young people living with long term conditions are vulnerable to health service disengagement and this 
endangers their long term adult health. This can be particularly problematic at the time of transition from 
paediatric to adult services. Poor transition can lead to disengagement from health services and poorer health 
outcomes (1-3). For example, 35% of young renal transplant recipients loose their transplants by 36 months 
with a large peak of graft loss between the ages of 20-24 years (4); The number of 20-24 year olds with diabetes 
having their HbA1c measured drops by >5% compared to the number of 10-19 year olds (5) and overall health 
outcomes compare poorly with those for an adult population (6). With sickle cell disease regular attendance at 
outpatient clinics and adherence to penicillin prophylaxis declines (7-9) in the context of  25% of sickle cell 
deaths in young people being  linked to infection (10). 
 
Research suggests that service level factors that affect engagement with health care, of young people with long 
term conditions, include: poor patient-clinician communication, inflexible access to people and information, 
lack of person-centred health care and the need for continuity and relationship development (11-13). Several 
studies report requests for the use of digital forms of communication - email, text and social media - with their 
health care team (11, 14). 
 
The use of these methods of digital clinical communication is troublesome for the NHS. Most clinical 
professional bodies proffer caution in their use (15); NHS Trusts lack information governance policies to 
regulate and monitor this clinical activity and infrastructure to safeguard the use of digital clinical 
communications is locally determined. This context makes the real life evaluation of the role of digital clinical 
communication complex for clinicians, individual Health Care Trusts and the NHS.  
 
Evidence of the effects of digital clinical communication internationally from systematic reviews across a range 
of long term conditions and across the lifespan is equivocal although no trials report poorer outcomes in the 
experimental digital communication arm. It is difficult to ascertain what contributes to positive effects on health 
outcomes where these are found, due to population heterogeneity and study quality. Several reviews found 
patient engagement with health care providers increased (17, 21, 22, 25); asynchronous communications were 
found to lead to greater improvements in glycaemic control and self-care outcomes and synchronous 
interventions being more user friendly and more cost effective for patient and provider with combined 
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interventions leading to greatest quality of life improvements (26). Negative impacts include increased 
depression, deteriorated parental relationships and information overload (26). The evidence continues to have 
much uncertainty contained within it despite considerable research endeavour.  However, the reviews highlight 
priority topics for future research to fill gaps in the evidence.  
 
Seventeen published reviews were identified (16-33) from which the following research recommendations were 
made: the importance of understanding what was important to patients, public and clinicians; costs associated 
with health care resource use by patients and health professional workload in meeting patient demand (22, 23); 
the information security, confidentiality and privacy issues related to digital clinical communication; 
development of broader policy guidelines; need to develop an evidence base across conditions and clinical 
contexts (17, 19, 25, 30); the need for a deeper understanding of these interventions, the moderators and 
mediators of change and the theoretical basis for assuming effectiveness and how all this links to desired 
outcomes such as A&E attendance, hospitalisations and clinical outcomes (22, 26, 30); the need to explore any 
impact on the patient-clinician relationship including how patients and clinicians negotiate health needs and 
health care. From a research design perspective, research involving a more diverse population and using 
qualitative methods was recommended. Our research tackles a number of the priority topics identified by these 
systematic reviews.  
 
In this evaluation of the use of digital communication between patient and clinician on clinical matters in the 
UK NHS, we will study digital clinical communication technology as it is currently being used, in its various 
technical forms and draw out results that are transferrable across technologies and across conditions. The digital 
communication ecosystem is rapidly changing (34) and this enables us to future proof our findings. Our Patient 
and Public Involvement (PPI) activity with young people previously undertaken suggests that the comparison 
across different diseases of the use of digital clinical communication will provide important insights. 
 
Aims, research question and objectives 
 
The overall research question is: “What are the effects, impacts, costs and necessary safeguards for digital 
clinical communications for young people living with long term conditions and engaging with NHS providers?”. 
The research has two aims: 1) To evaluate the impacts and outcomes of digital clinical communications for 
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young people living with a long term condition; 2) To provide a critical analysis of the use, monitoring and 
evaluation, of digital clinical communications by NHS providers. 
 
The objectives are as follows: 
1) To engage young people, including those with long term conditions, in the implementation of the research. 
2) To evaluate and synthesise published evidence on the use of digital clinical communication by health 
professionals with young people with long term conditions.  
3) To identify from the perspective of patients, clinicians, clinic support staff, clinical and IT managers and 
information governance specialists the issues, concerns, opportunities and solutions for the use of digital 
clinical communication in the NHS for a variety of clinical conditions;  
4) To investigate the impact of digital clinical communications on health outcomes for young people with long 
term conditions and on their engagement with, and use of, health services.  
5) To describe the cost of implementation and on-going provision of digital clinical communication and how it 
varies across different clinical conditions, to understand the value of this service to patients and clinicians, 
to understand the cost of up-scaling. 
6) To recommend outcome measures for future cost-effectiveness studies across disease areas. 
7) To develop and disseminate guidance for NHS providers and commissioners on policy, procedures, service 
management and payback in return for investment and guidance on which clinical areas are most likely to 
benefit. 
8) To consider the need for and design of future cost-effectiveness research. 
 
Study design 
 
The research involves: 1) Patient and Public Involvement activity; 2) literature review; 3) case studies – the 
main empirical part of the study - and 4) synthesis and a consensus meeting (see figure 1). The design for the 
empirical case studies uses a mixed methods case study design. Qualitative data from interviews and non-
participant observation of practitioners and patients communicating in up to 20 specialist clinical settings will be 
combined with quantitative data, aggregated at the case level (non-identifiable patient data), on a range of 
clinical outcomes meaningful within the case and across cases. We will seek to describe the use of digital 
clinical communication from the perspective of all the stakeholders in the clinic (patients/clinical staff/support 
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staff/managers). Following the definition of a case study by Robert Yin (35) as ‘an empirical inquiry that 
investigates a contemporary phenomenon in depth and within its real-life context, especially when the 
boundaries between phenomenon and context are not clearly evident’ (page 18), our ‘contemporary 
phenomenon’ for study is the use of digital clinical communication, and the ‘real-life context’ is the NHS, in 
particular specialist care provision for young people with long term conditions. Our initial propositions to focus 
our research (35) are: 1) young people between the ages of 16-24yrs in 2014 are digital natives and use, or 
would use, digital clinical communication in preference to other means of communication with their clinical 
team as this fits with their day to day mode of communication; 2) digital clinical communication is used by 
clinicians to promote the engagement with health care of young people with long term conditions with the aim 
of improving their health outcome, even if it puts at risk other aspects of clinical service provision (e.g. record 
keeping). These propositions suggest where to look for evidence to answer our research questions – the young 
people and the clinical teams. Thus our unit of analysis will be the young person with a long term condition in 
communication with their clinical teams (i.e. young person-communication-clinical team). This unit of analysis 
is embedded in the wider clinic, the technology through which the communication is conveyed, the NHS 
generally and contemporary society (35). 
 
Methods 
 
Ethical approval was obtained from UK NRES Committee West Midlands - The Black Country 13th March 
2014; REC reference 14/WM/0066; IRAS project ID: 147967. 
 
Public and patient involvement 
This activity involves young people and aims to capture their ideas, views and concerns on the subject of our 
research and its conduct. We will recruit young people through schools and other educational institutions to 
engage in workshops (approx. 10 institutions for each workshop sending two young people). The young people 
gain an extra curricula experience that will broaden their knowledge of health and research and will contribute 
significantly to their personal statement or CV. Their educational institution gains an enriched curriculum for 
their students and the research team gains input from the young people. Not all the young people involved will 
have a long term condition themselves but many will be close to someone who does. By drawing on a general 
population of young people we avoid focusing on specific conditions. The young people will be trained during a 
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one day workshop in research methods. They develop their own questions from our suggested topics and write a 
protocol for collecting data from peers (survey or interview usually using digital media). Within their 
educational institution they execute their mini-research project over a few weeks. At a second one day workshop 
the young people are trained in analysis, analyse their own data and write a report. Each set of workshops 
focuses on one of the following: 
1) Development of propositions to inform case study design: Why do young people with long term conditions 
want to contact their clinical team digitally? Why do they choose to use a particular digital medium? 
2) Recruitment and research design: Are we asking young people the right questions in the right way? Which 
young people would we miss out? What would young people like to ask health professionals about digital 
clinical communication? Which patient reported outcome measure is appropriate for use across a wide 
range of conditions (informed by literature review)? 
3) Analysis and dissemination: Is our analysis capturing the messages and themes communicated by young 
people? Are young people saying what we think they are saying? What are the important messages from 
our research for clinicians, commissioners and policy makers? 
Evidence from all the projects will be synthesised to inform study design. 
 
Literature reviews 
Using published peer reviewed research literature and grey literature we will seek to answer the following 
research questions concerning the UK NHS provision of digital clinical communication for young people with 
long term conditions: 
a) What generic outcome measures are available to assess the impact of digital clinical communication? 
b) How and for what purpose is this form of communication taking place (or not) in the UK? 
c) What is the ethical, legal, policy and governance framework for digital clinical communication? 
d) What is the evidence in the literature to support, challenge or add value to the case study findings? 
 
Review a). An initial search strategy will be developed for MEDLINE and adapted and refined for other 
databases. Keyword combinations and specific search terms will be used, focusing on the concepts of digital 
communication, ongoing patient/clinician interaction, specific technologies (e.g. text messaging) and systematic 
reviews. 
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The following electronic bibliographic databases will be searched: Cochrane Library (including Cochrane 
Systematic Reviews, DARE, CENTRAL, NHS EED, and HTA databases), MEDLINE, MEDLINE In-progress 
& Other Non-Indexed Citations, EMBASE, PsycINFO and Web of Science (including Science Citation Index 
and Conference Proceedings). Citations in eligible papers and previous reviews in the subject areas will be 
examined for additional papers that meet the inclusion criteria. Supplementary searches will be undertaken to 
find additional studies published since the systematic reviews, including scrutiny of references of included 
studies, citation searching, and searching relevant websites. 
 
Papers will be selected for inclusion if they meet the following criteria:  
a. All papers are systematic reviews and include at least one RCT 
b. Focus on any chronic health conditions (including physical and mental)  
c. All papers should include at least one outcome measure that assesses the impact of digital clinical 
communication  
d. Outcome measures could be assessed using either validated or non-validated scales 
e. The paper is published in English only 
f. The reviews should include studies with primary data 
g. Involves communication in both directions – patient to clinician and clinician to patient  
h. The types of technologies we will include are as follows: email, text messaging, social media and web 
based patient portals, and Voice over Internet Protocol (VoIP) (e.g. Skype and Google Talk) which can 
simultaneously transmit voice and other media such as text and images 
i. Where the use of a digitally delivered intervention or the delivery of disease prevention and health 
promotion information forms part of on-going patient-clinical team communication, they will be 
included 
 
Papers will be excluded if they: 
a. Involve measures aimed at non-English speaking populations  
b. Are independent studies, case-reports, case-series, retrospective observational studies, editorials or 
comments 
c. Deliver therapeutic interventions via digital communication media such as cognitive behavioural 
therapy, psychotherapy or psychiatry  
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d. Involve digital communication that solely involves the delivery of information on disease prevention 
and health promotion 
e. Involve technologies that provide a service that is the same as a telephone consultation 
f. Involve one-way communication 
g. Involve automated communication (e.g. automatic text messages as reminders) 
h. Focus on health behaviours (e.g. smoking cessation, weight management) 
i. Involve communication patient-patient (e.g. online support groups) or clinician-clinician 
 
The search will not be limited by date, populations, or health conditions. One reviewer will screen all identified 
bibliographic records for titles/abstracts and identified potential papers meeting the inclusion criteria. Two 
reviewers will independently screen a portion of the records and discuss any disagreements. One reviewer will 
extract relevant data on age groups, long-term conditions, digital interventions, generic and condition-specific 
outcome measures, and validated generic outcome measures (scales’ names, descriptions and full references). 
Data extraction will be checked by a second researcher and disagreements resolved through discussion. 
 
All scales for validated generic outcome measures and scales references will be obtained. We will review the 
outcome measures identified by seeking evidence of the development or evaluation of the measures. We will 
exclude measures where we are unable to identify any evidence of reliability or validity. Using the COSMIN 
checklist (36) we will assess each measure for the methodological quality of development studies, measurement 
properties, and interpretability and generalisability of the measurement results. We will summarise the findings 
in a form accessible to the Management Group and to young people engaging in Patient and Public Involvement 
activities. 
 
Review b) This exploratory literature review will identify reports of the use of digital clinical communication by 
specialist NHS providers in the UK. We will search both peer review and grey literature. The review will alert 
us to potential case study sites. 
 
Review c) We will collate relevant ethical, legal, policy and governance documents and summarise them to 
inform case study data collection. 
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Review d) During analysis of case study data we will identify topics for up to six rapid scoping reviews. The 
reviews will aim to find evidence that supports or challenges or in some other way adds value or a wider 
dimension to the case study findings and places the case study findings in a wider research context.  The exact 
inclusion and exclusion criteria for each of these reviews will be determined by the results of the case studies. 
For example, we may seek to evaluate clinical trial evidence for a specific type of participant (e.g. diabetes), 
intervention (e.g. mobile phones), outcomes (e.g. reduction in HbA1c). In this fast changing field it may be 
necessary to extend the existing review of factors that promote or inhibit the implementation of e-health systems 
(37). If social media are found to be important we may extend our own theory based review of their use (38) and 
the recent systematic review (39). Another possibility is a review of qualitative evidence. Each review will 
summarise the available literature from the previous five-year period in tables with a narrative synthesis and 
discussion of findings. 
 
Case studies 
 
Recruitment and sampling 
Inclusion and exclusion criteria. We will study specialist clinics or clinical teams who provide mostly outreach 
services and that provide NHS health care to young people (aged 16-24 years) with long term physical/mental 
health conditions which currently or potentially have serious health implications for the young people and are 
expensive to treat now or in the future. 
 
We will include asynchronous communication technologies such as email, text messaging, social media and 
web based patient portals. We will also include synchronous technologies such as Voice over Internet Protocol 
(VoIP) (e.g. Skype and Google Talk) which can simultaneously transmit voice and other media such as text and 
images. Currently, these systems usually use the internet or mobile phone infrastructures with crossover 
between these infrastructures. If other digital communication technologies come into common use during the 
project we will include them if we identify clinics where they are used for clinical communication. We are not 
intending to include technologies that provide a service that is all but the same as a telephone consultation as 
there is a large body of evidence on clinical telephone consultations. 
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Our research is concerned with communication between patients and specialist (secondary or tertiary care) 
clinicians/clinic teams who have already been in contact with each other in the clinical setting. Our focus is on 
systems of communication where there is, or is potentially, communication in both directions – patient to 
clinician and clinician to patient. We are not including specifically the delivery of therapeutic interventions via 
digital communication media (40) such as cognitive behavioural therapy (41)  nor are we including digital 
communication that solely involves the delivery of information on disease prevention and health promotion 
(42). Where the use of a digitally delivered intervention or the delivery of disease prevention and health 
promotion information forms part of on-going patient-clinical team communication, they will be included.  
 
Identification and sampling of study sites. Up to sixty sites will be identified from publically available literature, 
through posing questions on the internet aimed at young people with chronic conditions and through snowball 
sampling through relevant clinical networks. From these sites, up to 20 will be recruited. The lead 
clinician/manager of each potential clinical site will be contacted by letter and phone to explain the study and 
seek their agreement to an initial telephone interview. During the initial telephone interview we will ask about 
the nature of the clinical team and the use of digital clinical communication to inform our sampling. We will 
also seek agreement to participation in the study if their clinical team was to be sampled, and seek information 
on barriers to participation (e.g. upcoming move of clinic location). We will then sample from those that have 
agreed to participate. This will aim to achieve diversity of health condition, type of technology and degree of 
integration of the digital clinical communication within the routine work of the clinic, along with diversity of 
geographical location and regional or district specialist clinical teams. We will sample clinical sites so that each 
is different from the last on one or more of these criteria. Recruitment will stop when we have included a 
diversity of clinical teams and we reach data saturation. We will also consider the need to collect data to provide 
contrasts between clinical teams for analysis. For example, if a clinic is actively using digital clinical 
communication for advising patients on changing medication regimes, we would aim to recruit a clinical team 
that undertakes similar clinical activity but not using digital clinical communication. 
 
Ethical issues. We will be asking health care staff to talk about practices that may be contravening NHS current 
Information Governance guidance. Health professionals are responding to the needs and demands of their young 
patients by using digital communication that does not necessarily meet the NHS Information Governance 
criteria. To collect rich data we will emphasise the confidentiality of the research data and that we are collecting 
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data from many clinics so it will not be possible to identify specific clinics/staff from our research report. We 
will have an ethical protocol in place for considering breaches of Information Governance policy and 
professional standards. We do not expect to take action for activity that we find is common practice but will be 
alert to serious breaches of policy and professional standards. We will steer a careful path here as clinicians 
using digital clinical communication will be rich sources of data for the project. We will ensure transparency of 
ethical process. 
 
Study site recruitment. A briefing meeting will be held with staff members during which a timetable of data 
collection will be drawn up to maximise opportunity for data collection and minimise disruption to the clinic. 
Information about the study will be distributed to all clinic staff members and posters about the study to be 
displayed in the clinic for both staff and patients to see for the duration of the fieldwork. 
 
Recruitment of clinic staff for interview and informed consent. During the clinic field work we will sample 
health professionals working in the clinical team who use or would potentially use digital clinical 
communication (nurses, doctors, professions allied to medicine) and administrative, managerial and technical 
staff who provide support, including IT manager and Information Governance specialists. Sampling will be 
purposive for diversity of experience and opinion about digital clinical communication within each case study. 
We will aim for data saturation for each clinic and expect to undertake individual interview with up to 15 clinic 
staff. In some clinics the number needed to reach saturation may be as low as 4 or 5. Clinicians may decline to 
be interviewed despite the clinic being a case study site. For the collection of data about the processes of the 
clinic (e.g. patient flows, staff tasks), where convenient for the staff, we may interview several members of staff 
together. Written consent will be obtained at the beginning and confirmed at the end of each interview with 
clinicians.  
 
Recruitment of patients for interview and informed consent. Patients with appointments to consult with a clinical 
team member will be identified and sent a study information sheet two weeks before their appointment. Those 
who agree to interview will be given either an appointment time for interview that fits with their clinic 
attendance or arrangements will be made for telephone/Skype or email/Facebook (and similar) interview, 
whichever is preferred by the patient. Consent will be taken before the interview commences. Where an 
interview is held over the telephone, consent will be taken verbally. Patients will be offered a thank you token of 
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a £20 High Street voucher. During interview the patient will be asked about the study team interviewing their 
parent/carer/household member (e.g. girl/boyfriend or wife/husband). The patient will make the decision as to 
whether they are willing for the parent/carer/household member to be interviewed. If they are willing, they will 
be asked to pass a participant information sheet to the parent/carer/household member and to provide their 
contact details. If consent is given these interviews will usually be by telephone or email. Consent will be 
collected as for the patient. We are including patient/carer/household member interviews as these people may be 
involved in digital clinical communication, particularly for the lower ages in our study and where patients 
potentially become seriously ill. 
 
Although phone and email interviews might not give as rich data as face to face, we will offer a choice to 
encourage participation. Interview length is likely to range from a 45 minute face to face interview after clinic 
through to one email exchange. Guided by clinic staff, we will purposively sample for current users, past users 
and non-users of digital clinical communication, patients from localities with low socio-economic indicators and 
patients from ethnic minorities. As well as digital communication users, we will aim to recruit for interview 
patients who are or might be excluded from the use of digital communication media due to lack of resource, due 
to disabilities or because they do not want to use them. Where necessary we will employ an interpreter to assist 
with communication at recruitment and for undertaking interviews for people unable to communicate in 
English. We will aim for a diversity of patients and data saturation within each clinic and expect to interview up 
to 15 patients or patient/parent/carer/household member dyads. Where patient and parent/carer/household 
member are both interviewed, we will interview them separately if they agree. 
 
Data collection 
Through our observation and exploring the perceptions of patients and clinical team members, we seek data on 
what happens in the clinic, why it happens and its impact. Within this realist approach (43) data collection will 
be guided by existing theory concerning the implementation of innovation in particular the Comprehensive 
Framework for Implementation Research (CFIR)(44) and Normalisation Process Theory (NPT) (45, 46). CFIR 
is a framework developed from extensive literature review and synthesis of theories that identifies five major 
domains for exploration when evaluating the implementation of change in health care organisations: the 
intervention, inner and outer setting, the individuals involved, and the process by which implementation is 
accomplished. NPT was developed from empirical studies and considers the actions of people when 
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implementing a change or new technology into their working practices. It considers four constructs of actions: 
coherence, cognitive participation, collective action and reflexive monitoring. We will use these theories to 
sensitise us to the areas to explore in data collection. For example, in the CFIR the domain of intervention 
characteristics includes stakeholder’s perception of the advantage of implementation of the intervention, its 
adaptability, the potential for testing the intervention on a small scale, and its complexity. Similarly, NPT 
suggests questions such as whether the intervention fits within the overall goals of the organisation. However, 
we will not be constrained by these theories and will actively seek other relevant data. 
 
Documentary analysis. With the assistance of each clinic’s lead clinician/manager, we will collate and 
summarise current policies and procedures. We will ask the clinical lead/manager to tell us about any reported 
incidents or adverse events related to digital clinical communication that have occurred in the previous three 
years. 
 
Non-participant observation. The researcher will observe how the clinic functions and ask clarifying questions 
guided by an observation proforma. Clinic staff will be shadowed for up to two hours at any one time and up to 
four times during data collection to observe different types of clinic activity. Observation data will include: who 
uses digital clinical communication, where, when, why and for what purpose, frequency of digital clinical 
communications, and the length of time spent dealing with these communications. Field notes will be taken. 
These notes will be reviewed and adjustments made to observation plans to ensure all aspects of relevant 
clinical team activity is observed. 
 
Collection of impact data. The researcher will establish during observation, how any use of digital clinical 
communication is being or could be evaluated for its intended objectives. If a clinic has evaluated their use of 
digital clinical communication, we will seek access to this evaluation. If not, with the clinic team, we will plan a 
retrospective evaluation using available data. If the purpose of the digital clinical communication was to 
improve concordance with treatment or monitoring regimens then we will seek data that reflects this (for 
example, a routinely used clinical indicator). If the purpose was to improve access to advice and support at the 
time of need, we will assess whether this is taking place. The evaluation plan will include: time frame (before 
and after initiation of use), data relevant to objectives (e.g. blood test results), time points (e.g. annual data), 
clinic denominator (young people recurrently in contact with clinic team). The following data will be collected 
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where available for all clinical teams included in the case study for before and after initiation of the use of 
digital clinical communication (or for non-user clinics, over a similar period of time as for user clinics): Did Not 
Attend rates (excluding first appointments), emergency hospital admissions and Accident and Emergency 
Department  attendance rates. Where a clinic caters for adults we will limit the data to patients aged 16-24 years. 
Data will be extracted from exiting clinical and administrative data. 
 
Collection of economic data about the digital communication system. We aim to establish the direct cost 
involved with the development, implementation and day-to-day running of the technology used in the case study 
sites for digital clinical communication. We will determine, at each site, the extent to which the development, 
implementation and maintenance of technology has been managed internally, or commissioned from external 
specialists. For internally managed activity, we will identify staffing and equipment costs associated with these 
activities, and determine whether there were specific challenges or design features that were particularly costly 
to accommodate. We will also investigate costs associated with externally commissioned activities. 
 
Semi-structured interview content (staff, patients and parents/carers). Interviews will usually be brief (up to 45 
minutes), audio-recorded, and focused on the experience of using digital clinical communication. Interviews 
will be individual interviews. In advance, interviewees will be asked to bring to the interview examples of 
recent digital clinical communications (anonymised) and critical incidents as examples to inform interview 
discussion. These examples will not be given to the research team by health professionals. Patients and their 
parents/carers/household members, may choose to give the researcher these examples. 
 
In clinics where digital clinical communication is in use interviews will cover the following: 
- intended objectives of using digital clinical communication and whether or not they have been achieved 
- digital clinical communication actually used, why it was used and in what context 
- understanding of the nature of privacy and confidentiality in the context of digital clinical communication 
- understanding of the clinician’s duty of care and the patient-clinician relationship, including responsibility 
for care/self-care in this context. 
- features of the digital clinical communication system, the content of the communication and any contextual 
factors that contribute to its successful/unsuccessful use 
- perceived risks (patient safety, ethics, data storage) 
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- costs and benefits (patient experience, staff work experience, unintended consequences, impact on other 
services, financial costs and savings, evaluated health outcomes) 
- future implications from greater use of digital communications 
- needs or experience of training for using digital communication with patients/clinicians 
 
Within each interview we will also use a variation of the critical incident technique for both when digital clinical 
communication did and did not work well: tell me about a situation where the digital clinical communication 
did/did not work well for you; what happened (unfolding); what was the result (consequence); how did you cope 
(mitigation); what could have happened (worst credible effect)? 
 
To investigate the impact of digital clinical communication on staff workload, in interviews with staff, we will 
attempt to capture ways in which digital communication has increased their workload, or allowed them to work 
more efficiently. We will ask participants to quantify this impact as far as possible. 
 
The interview topics will be adapted for use in clinics where there is partial use or past use of digital clinical 
communication. Where it has not been used, interviews will seek to explore currently used processes of 
communication between clinicians and patients, attitudes to digital clinical communication and reasons for not 
using it, implications of greater use of digital communications including training needs. We expect to reach data 
saturation rapidly in these clinics. 
 
The interviews will be an opportunity to expose any generic measures identified in literature review to clinicians 
and young patients to ascertain to what extent the success or not of their digital service is captured by these 
outcome measures. If no generic measure has been found through literature review or if cumulative case study 
analysis identifies that existing measures are not viewed as adequate, then the interview and observational data 
will be used to develop items for a new generic scale to capture the impact of digital clinical communications. 
 
We will investigate the value patients place on digital clinical communication using a willingness-to-accept 
approach (47). Within the semi-structured interviews, patients will be asked to consider the hypothetical 
opportunity to receive payment (cash or vouchers) as an alternative to using the digital communication system, 
and indicate how much they would need to be offered to forego use of the system. 
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Data management and analysis 
All qualitative data will be given an identifier, typed up/transcribed and during this process anonymised. NVivo 
software will be used to manage this data and for coding. Retrospective quantitative clinic data will be obtained 
in aggregate form. Throughout analysis we will use standard techniques for quality checking including 
qualitative coding by independent researchers and investigation of outliers and non-standard responses. 
Qualitative analysis will be concurrent with data collection to ensure data collection ceases when data saturation 
is reached. We have developed analysis questions to ensure we meet the relevant study objectives. We describe 
below the analysis for each research question. However, each approach to analysis will inform others as they all 
form part of the same case study.  
 
Analysis questions: What works for whom, where, when and why? Given the research gaps identified related to 
the need for generalisable evidence across disease areas, we will focus analysis on the commonalities across the 
health conditions such as communication about medication or communicating results of investigations or 
symptom reporting or health service navigation, as one review (26) called it “the function of the 
communication”. We will follow Yin’s case study approach (35) combined with realist evaluation approach 
(43). We will identify in the data descriptions of actual events where digital clinical communication has been 
used. We will categorise these into configurations of context, mechanism and outcome, where context is 
proximal influences, mechanism is the digital communication and the interaction of the patient and clinician 
with that communication, and the outcome is proximal to the mechanism. (Illustrative example: context = young 
person experiencing psychosis + mechanism = SMS communication with mental health team aiming to maintain 
medication concordance > outcome: young person takes medication regularly.) From Patient and Public 
Involvement activity, from published studies and theory and from early data collection, we will develop 
propositions that are possible explanations of more distal outcome. To test each proposition, we will interrogate 
the categorised configurations of context-mechanism-outcome along with data about wider patient and clinic 
context, quantitative measures of outcome such as health status or service use and qualitative data that can 
explain the outcome. We will seek to confirm or refute the propositions and seek rival explanations. This will 
continue until we are finding no new data/patterns of data (data saturation) and so no evidence for revising the 
explanations further. We will then develop logic models which bring together explanations as a chain of events. 
These identify a context, with a mechanism that through intermediate steps produces a final outcome. The aim is 
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not to produce one logic model but a number of alternative models. (Illustrative example - context: mental 
health team working with young people in deprived inner city locality with high rates of admission for 
psychosis plus mechanism: SMS messages remind young people about medication and young people can report 
side effects > proximal outcome: young people are concordant with medication > subsequent outcome: fewer 
acute psychotic episodes > distal outcome: reduced rates of admission. The construction of these logic models 
will draw on earlier analysis and on wider relevant research literature. 
 
Analysis question: Using existing clinical data, what is the impact of digital clinical communications on the 
health status and behaviours of patients? Data on how the impact on health status of patients is currently 
evaluated in relation to the use of digital clinical communication will be extracted from the case study material 
and summarised for each clinic. The data extracted from routine clinic records for the planned clinic 
evaluations, will be analysed using descriptive statistics, cross-tabulations, and statistical tests of association. To 
analyse the difference in ‘Did Not Attend’ (DNA) rates before and after implementation of the use of digital 
clinical communication we will report the proportion of DNA patients and calculate the difference in these 
proportions with the appropriate 95% confidence interval based on a delta-method standard error for the 
difference in proportions. We will also report the P-value from the test of the difference in binomial proportions 
(48). We will also report similar analyses for rates of emergency hospitalisation, and rates of Accident and 
Emergency department attendance. 
 
We will compare rates between clinics to understand overall trends and any exceptions. For example, use of 
digital clinical communication may be associated with increased Accident and Emergency department 
attendances for one long term condition and not another. We will also compare study clinics with published data 
for the same condition and its management in the UK. Statistical modelling of each outcome (‘Did Not Attend’, 
emergency hospitalisation, and Accident and Emergency attendance) will be performed using multilevel mixed 
effects logistic regression using clinic level random effects and treating the before and after ‘Did Not Attend’ 
data (and data at any additional time points) as repeated measures (49). This will allow estimation of an intra-
class correlation coefficient for the proportion of variance explained by the within clinic variance. The use of 
digital clinical communication will be included in the model as a binary covariate allowing estimation of an 
odds ratio for the specific outcome for the effect of digital communication. 
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Analysis questions: What value do patients place on digital clinical communication? What are the direct 
resource use implications for the NHS of implementing it? How does the direct resource use vary when used 
with different patient groups? What are the resource implications for scaling up in the NHS? To understand the 
value patients place on digital clinical communication we use the willingness-to-accept approach and link the 
answers to data from patients (or patient/parent carers) on their experience with such communication, to better 
understand what aspects are highly valued. Data collected from the case study sites about cost, design features, 
staff work load and time will be combined with evidence from the literature to build up a picture of the costs 
associated with digital clinical communication, and the immediate benefits to patients and health care 
professionals. We will explore how these costs and benefits vary according to the design of the system and the 
disease area where it is used. We will also explore the extent to which costs are fixed or vary with size, in order 
to explore the impact of scaling up particular interventions to be available across the NHS.  
 
Analysis questions: What concerns do patients and clinicians have about confidentiality in relation to digital 
clinical communication? How does it affect the patient/clinician relationship and the clinician’s duty of care? 
What regulatory framework is needed to reassure patients and clinicians regarding its use? Given the research 
gaps identified in relation to privacy and data protection and the effect of digital clinical communication on the 
patient-clinician relationship, we will include an empirical ethical analysis of interview and observational data 
focussing on patients and clinicians views on the nature of confidentiality and privacy, clinical duty of care, and 
trust between patient and health care professional in the context of their experience of digital clinical 
communication. We will follow the method described by Ives and Draper for ‘normative policy oriented 
empirical ethics’ (50). This approach recognises the need for ethical policy (in this case policy on the use of 
digital clinical communication) to be informed by both a theoretical analysis of the ethical concerns and the 
moral intuitions of the relevant stakeholders. Analysis involves an iterative process of reflective equilibrium 
between the empirical data (intuitions of patients and clinicians on confidentiality and trust in the context of 
digital clinical communication) and theoretical analysis (ethical and legal discourse on confidentiality and duty 
of care).  
 
Analysis question: What are the significant risks to patient safety associated with the use of digital clinical 
communication in the context of supporting young people with chronic disease? The introduction of technology 
may change the way in which a service is delivered and used.  It is important to identify proactively and to 
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assess any potential threats to patient safety that may arise as a result of this.  Such a risk assessment needs to 
consider both intended use scenarios as well as scenarios where the technology may be used in ways that may 
not have been intended (reasonably foreseeable misuse).  In addition, credible failure scenarios (i.e. situations 
where use of the technology fails) need to be identified and their impact on patient safety assessed.  The risk 
analysis will be informed by: (a) consideration of actual events through the study of incident reports from the 
participating organisations as far as these are available to the research team, and (b) perceptions of staff and 
patients elicited through the semi-structured interviews using a variation of the critical incident technique 
(described above). 
 
Analysis question: In future, how can its effectiveness be measured across health conditions? We will undertake 
thematic analysis of qualitative data from the case studies specifically for aspects of impact. We will continue 
analysis of data until no new themes are being found. Themes will be summarised and compared with those 
covered by existing generic measures identified from the literature review or will be developed into a draft 
outcome measure for future development and testing beyond the scope of this study. 
 
Consensus meeting 
Research questions: What are the risks to patients and to NHS specialist care providers of the use of digital 
clinical communication? What policy and procedural changes are needed for gaining benefit and limiting 
harm? In which clinical areas is benefit most likely, and how is benefit most likely to be achieved? What future 
evaluation is needed and how should it be undertaken? The results of each of our analyses will be interrogated 
to answer each of the above questions. These answers will then be presented at a consensus meeting along with 
a series of scenarios based on the study results as illustration. There are various designs for running consensus 
meetings (51). We will ensure attendees have experience or insight relevant to the topic, and bring a range of 
views (52). We will invite national stakeholders (approximately eight) representing various aspects of health 
care provision for young people, recruit young people (approximately eight) and representatives of specialist 
service providers (approximately eight). We will advertise for young people to attend among all those who 
engaged with Patient and Public Involvement activities, as these young people will already have developed 
some insights into the issues. We will advertise for representatives of specialist service providers by contacting 
all providers who expressed an interest in the research (even if they did not become a study site). We will 
identify relevant national stakeholders including representatives of policy making bodies, professional 
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associations and educational organisations. The format will be a modified form of the NIH Consensus 
Development Conference (52). The form of consensus may be agreement about the multiple options available 
and the caveats that apply to different contexts. The meeting will run as follows: a series of short presentations 
on the different aspects of the study; discussion of the scenarios in small groups followed by plenary feedback 
and discussion; in different small groups consideration of each of the research question for this work package; 
feedback to the whole group; continued discussion until consensus  is reached. The meeting will be chaired by a 
Patient/Public representative from the Project Management Group. 
 
Discussion 
 
This multi-method evaluation aims to understand the benefits, costs and consequences of the use of digital 
clinical communication in the UK NHS for people requiring specialist services for long term conditions. The 
study focuses on young people as for this cohort ability to use digital communication will not be a limiting 
factor. The evaluation will indicate where, when, how and with whom, digital clinical communication is 
currently used successfully, risks and procedures for minimising the risks of innovation, the risks of not 
innovating, and actual cost of provision including start up, continuation and up-scaling. Health professionals 
work within their professional guidelines and health care provider information governance policy. This study 
will provide evidence from which these can be developed and refined to enable appropriate use of digital 
clinical communication. The study will also provide evidence for successful implementation of digital clinical 
communication and suggest areas where further research on its use is needed. 
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Figure 1. Flow diagram showing links between research activities 
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